Compare Bio Protocol (BIO) vs Kaspa (KAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Kaspa — how do they compare? Bio Protocol trades at Rp514.13 (market cap Rp1,15T, Rp260,42M 24h volume), while Kaspa trades at Rp519.37 (market cap Rp14,35T, Rp146,25M 24h volume). The key difference: Kaspa is far larger — about 12.5× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 27,6B / 28,7B KAS (97%) for Kaspa. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Kaspa for 39 Days on average.
| BIO | KAS | |
|---|---|---|
Market Cap | Rp1,15T | Rp14,35T |
Volume (24h) | Rp260,42M | Rp146,25M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 27,6B / 28,7B KAS (97%) |
Typical Hold Time | 16 Days | 39 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Kaspa (KAS) trades at Rp521.31 with a market cap of Rp14.32T, showing a bearish technical signal as moving averages indicate strong selling pressure while oscillators remain neutral. The token is near full circulation at 97%, with key resistance at Rp525 and support at Rp508. No major protocol updates or ecosystem news are reported recently, keeping fundamental developments quiet.
Overall outlook is cautious due to bearish technicals and lack of catalysts, but oversold RSI hints at potential rebound opportunities. Major risks include high volatility, regulatory uncertainty in crypto markets, and thin liquidity; investors should monitor exchange volume and on-chain activity for signs of recovery.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Kaspa
Kaspa is a fast and scalable Layer-1 cryptocurrency built on a proof-of-work model, powered by the GHOSTDAG protocol. This protocol allows multiple blocks to coexist in a blockDAG structure. Kaspa can process 10 blocks per second, with plans to scale to 100 BPS, providing near-instant confirmation times. Designed for accessibility and decentralization, Kaspa runs smoothly on standard personal computers and supports future Layer-2 solutions for scalable and secure applications.
Read more on KAS →
